Alteri Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$629K Buy
4,978
+427
+9% +$56.3K 0.17% 144
2026
Q1
$634K Sell
4,551
-1,742
-28% -$244K 0.21% 128
2025
Q4
$772K Buy
6,293
+738
+13% +$89.7K 0.25% 95
2025
Q3
$617K Buy
5,555
+374
+7% +$42.5K 0.21% 119
2025
Q2
$574K Buy
5,181
+535
+12% +$56.9K 0.22% 114
2025
Q1
$521K Buy
4,646
+1,337
+40% +$138K 0.23% 111
2024
Q4
$306K Buy
+3,309
New +$298K 0.08% 176

Other funds holding GILD

Alteri Wealth's GILD Position: Q2 2026 in Review

Alteri Wealth increased its Gilead Sciences (GILD) stake by 9.4% in Q2 2026, buying an estimated $56.3K and bringing the position to 4,978 shares worth $629K. The position accounts for 0.17% of the portfolio, ranked #144.

Alteri Wealth first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $772K in Q4 2025. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Alteri Wealth held 4,978 shares of Gilead Sciences worth $629K as of Q2 2026.
  • Alteri Wealth bought 427 Gilead Sciences shares in Q2 2026, an estimated $56.3K.
  • Gilead Sciences made up 0.17% of Alteri Wealth's portfolio in Q2 2026, its #144 holding.
  • Alteri Wealth first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Alteri Wealth's Gilead Sciences position peaked at $772K in Q4 2025.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Alteri Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.